This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States
The drug RUXIENCE contains one active pharmaceutical ingredient (API):
|
1
Rituximab
UNII 4F4X42SYQ6 - RITUXIMAB
|
|
Rituximab binds specifically to the transmembrane antigen, CD20, a non-glycosylated phosphoprotein, located on pre-B and mature B lymphocytes. The antigen is expressed on >95% of all B cell non-Hodgkin’s lymphomas. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| RUXIENCE Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01FA01 | Rituximab | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FA CD20 (Clusters of Differentiation 20) inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 522720090089607, 522720090089707 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02495724 |
| Country: EE | Ravimiamet | Identifier(s): 1815522, 1815533 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1201431001, 1201431002 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 555963, 566176 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 66217549, 67613747 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 385891, 385919 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9093, 9094 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 048720015, 048720027 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1089842, 1089843 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 51004, 51012 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 21533, 21534 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100439201, 100439218 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66628001, W66629001 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8681308771032, 8681308771049 |
| Country: US | FDA, National Drug Code | Identifier(s): 0069-0238, 0069-0249 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
